Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ChromaDex Q4 EPS $0.00 Beats $(0.03) Estimate, Sales $21.20M Beat $20.98M Estimate

Author: Benzinga Newsdesk | March 06, 2024 05:05pm
ChromaDex (NASDAQ:CDXC) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.03) by 103.33 percent. This is a 105 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $21.20 million which beat the analyst consensus estimate of $20.98 million by 1.03 percent. This is a 0.95 percent increase over sales of $21.00 million the same period last year.

Posted In: CDXC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist